GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14.

S-nitrosation Colitis GSNOR MAPK14 NLRP3 inflammasome Septic shock

Journal

Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872

Informations de publication

Date de publication:
03 Apr 2024
Historique:
received: 03 09 2023
accepted: 17 03 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 3 4 2024
Statut: aheadofprint

Résumé

Hyperactivation of the NLRP3 inflammasome has been implicated in the pathogenesis of numerous diseases. However, the precise molecular mechanisms that modulate the transcriptional regulation of NLRP3 remain largely unknown. In this study, we demonstrated that S-nitrosoglutathione reductase (GSNOR) deficiency in macrophages leads to significant increases in the Nlrp3 and Il-1β expression levels and interleukin-1β (IL-1β) secretion in response to NLRP3 inflammasome stimulation. Furthermore, in vivo experiments utilizing Gsnor

Identifiants

pubmed: 38570588
doi: 10.1038/s41423-024-01155-9
pii: 10.1038/s41423-024-01155-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to CSI and USTC.

Références

Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.
pubmed: 31036962 pmcid: 7807242 doi: 10.1038/s41577-019-0165-0
Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278–86.
pubmed: 22258606 doi: 10.1038/nature10759
Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114–27.
pubmed: 34321623 pmcid: 8429580 doi: 10.1038/s41423-021-00740-6
Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301–16.
pubmed: 36750315 doi: 10.1146/annurev-immunol-081022-021207
Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18:1141–60.
pubmed: 33850310 pmcid: 8093260 doi: 10.1038/s41423-021-00670-3
Cornut M, Bourdonnay E, Henry T. Transcriptional regulation of inflammasomes. Int J Mol Sci. 2020;21:8087.
pubmed: 33138274 pmcid: 7663688 doi: 10.3390/ijms21218087
Luo F, Li H, Ma W, Cao J, Chen Q, Lu F, et al. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. Cell Mol Immunol. 2024;21:60–79.
pubmed: 38062129 doi: 10.1038/s41423-023-01112-y
Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X, et al. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflammation. 2021;18:123.
pubmed: 34059091 pmcid: 8166383 doi: 10.1186/s12974-021-02137-8
Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharm Sci. 2022;43:653–68.
pubmed: 35513901 doi: 10.1016/j.tips.2022.04.003
Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588–606.
pubmed: 30026524 doi: 10.1038/nrd.2018.97
Zeng J, Xie X, Feng XL, Xu L, Han JB, Yu D, et al. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice. EBioMedicine. 2022;75:103803.
pubmed: 34979342 doi: 10.1016/j.ebiom.2021.103803
Qin Y, Li Q, Liang W, Yan R, Tong L, Jia M, et al. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation. Nat Commun. 2021;12:4794.
pubmed: 34373456 pmcid: 8352945 doi: 10.1038/s41467-021-25033-4
Haneklaus M, O’Neill LA, Coll RC. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr Opin Immunol. 2013;25:40–5.
pubmed: 23305783 doi: 10.1016/j.coi.2012.12.004
Di Q, Zhao X, Tang H, Li X, Xiao Y, Wu H, et al. USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy. Autophagy. 2023;19:873–85.
pubmed: 35900990 doi: 10.1080/15548627.2022.2107314
Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. 2016;45:802–16.
pubmed: 27692610 doi: 10.1016/j.immuni.2016.09.008
McKee CM, Coll RC. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma. J Leukoc Biol. 2020;108:937–52.
pubmed: 32745339 doi: 10.1002/JLB.3MR0720-513R
Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410:490–4.
pubmed: 11260719 doi: 10.1038/35068596
Jiao L, Su LY, Liu Q, Luo R, Qiao X, Xie T, et al. GSNOR deficiency attenuates MPTP-induced neurotoxicity and autophagy by facilitating CDK5 S-nitrosation in a mouse model of Parkinson’s disease. Free Radic Biol Med. 2022;189:111–21.
pubmed: 35918012 doi: 10.1016/j.freeradbiomed.2022.07.016
Liu Q, Gu T, Su LY, Jiao L, Qiao X, Xu M, et al. GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation. Redox Biol 2021;47:102172.
pubmed: 34678655 pmcid: 8577438 doi: 10.1016/j.redox.2021.102172
Zhang Y, Wu K, Su W, Zhang DF, Wang P, Qiao X, et al. Increased GSNOR expression during aging impairs cognitive function and decreases S-Nitrosation of CaMKIIα. J Neurosci. 2017;37:9741–58.
pubmed: 28883020 pmcid: 6596611 doi: 10.1523/JNEUROSCI.0681-17.2017
Chatterji A, Banerjee D, Billiar TR, Sengupta R. Understanding the role of S-nitrosylation/nitrosative stress in inflammation and the role of cellular denitrosylases in inflammation modulation: implications in health and diseases. Free Radic Biol Med. 2021;172:604–21.
pubmed: 34245859 doi: 10.1016/j.freeradbiomed.2021.07.015
Barnett SD, Buxton ILO. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. Crit Rev Biochem Mol Biol. 2017;52:340–54.
pubmed: 28393572 pmcid: 5597050 doi: 10.1080/10409238.2017.1304353
Tang X, Pan L, Zhao S, Dai F, Chao M, Jiang H, et al. SNO-MLP (S-Nitrosylation of muscle LIM protein) facilitates myocardial hypertrophy through TLR3 (Toll-Like Receptor 3)-mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) inflammasome activation. Circulation. 2020;141:984–1000.
pubmed: 31902237 doi: 10.1161/CIRCULATIONAHA.119.042336
Tang X, Zhao S, Liu J, Liu X, Sha X, Huang C, et al. Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation. Circ Res. 2023;133:220–36.
pubmed: 37377022 doi: 10.1161/CIRCRESAHA.123.322654
Patel MN, Carroll RG, Galvan-Pena S, Mills EL, Olden R, Triantafilou M, et al. Inflammasome priming in sterile inflammatory disease. Trends Mol Med. 2017;23:165–80.
pubmed: 28109721 doi: 10.1016/j.molmed.2016.12.007
Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, et al. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021;18:1425–36.
pubmed: 33972740 pmcid: 8166941 doi: 10.1038/s41423-021-00683-y
Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59:1192–9.
pubmed: 20442201 doi: 10.1136/gut.2009.197822
Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6:e134601.
pubmed: 33350984 pmcid: 7934863 doi: 10.1172/jci.insight.134601
Lin Y, Li Z, Wang Y, Tian T, Jia P, Ye Y, et al. CCDC50 suppresses NLRP3 inflammasome activity by mediating autophagic degradation of NLRP3. EMBO Rep. 2022;23:e54453.
pubmed: 35343634 pmcid: 9066065 doi: 10.15252/embr.202154453
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–49.
pubmed: 8350599
Ma H, Hu T, Tao W, Tong J, Han Z, Herndler-Brandstetter D, et al. A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis. Cell Res. 2023;33:372–88.
pubmed: 37055591 pmcid: 10156687 doi: 10.1038/s41422-023-00790-7
Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:15 25 1–15 25 14.
pubmed: 24510619 doi: 10.1002/0471142735.im1525s104
Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006;24:317–27.
pubmed: 16546100 doi: 10.1016/j.immuni.2006.02.004
Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci. 2022;14:879021.
pubmed: 35754962 pmcid: 9226403 doi: 10.3389/fnagi.2022.879021
Chen Y, Wang CY, Zan GY, Yao SY, Deng YZ, Shu XL, et al. Upregulation of dynorphin/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion. Acta Pharm Sin. 2023;44:538–45.
doi: 10.1038/s41401-022-00987-3
Engeland K, Höög JO, Holmquist B, Estonius M, Jörnvall H, Vallee BL. Mutation of Arg-115 of human class III alcohol dehydrogenase: a binding site required for formaldehyde dehydrogenase activity and fatty acid activation. Proc Natl Acad Sci USA. 1993;90:2491–4.
pubmed: 8460164 pmcid: 46113 doi: 10.1073/pnas.90.6.2491
Wu K, Ren R, Su W, Wen B, Zhang Y, Yi F, et al. A novel suppressive effect of alcohol dehydrogenase 5 in neuronal differentiation. J Biol Chem. 2014;289:20193–9.
pubmed: 24895131 pmcid: 4106335 doi: 10.1074/jbc.C114.561860
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6:150–66.
pubmed: 15688001 doi: 10.1038/nrm1569
Yang L, Calay ES, Fan J, Arduini A, Kunz RC, Gygi SP, et al. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction. Science. 2015;349:500–6.
pubmed: 26228140 pmcid: 4573582 doi: 10.1126/science.aaa0079
Altman MC, Baldwin N, Whalen E, Al-Shaikhly T, Presnell S, Khaenam P et al. A transcriptome fingerprinting assay for clinical immune monitoring. bioRxiv. 2019:587295. https://doi.org/10.1101/587295 .
Irie T, Sips PY, Kai S, Kida K, Ikeda K, Hirai S, et al. S-Nitrosylation of calcium-handling proteins in cardiac adrenergic signaling and hypertrophy. Circ Res. 2015;117:793–803.
pubmed: 26259881 pmcid: 4600453 doi: 10.1161/CIRCRESAHA.115.307157
Bauer C, Duewell P, Lehr HA, Endres S, Schnurr M. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis. 2012;30:82–90.
pubmed: 23075874 doi: 10.1159/000341681
Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379–91.
pubmed: 20303296 pmcid: 2982187 doi: 10.1016/j.immuni.2010.03.003
Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207:1045–56.
pubmed: 20385749 pmcid: 2867287 doi: 10.1084/jem.20100050
Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. Sci Adv. 2019;5:eaau7426.
pubmed: 30662948 pmcid: 6326752 doi: 10.1126/sciadv.aau7426
Meng G, Kirschning CJ, Zhou R. Editorial: patho- and physiological roles of inflammasomes. Front Immunol. 2022;13:857929.
pubmed: 35296078 pmcid: 8919720 doi: 10.3389/fimmu.2022.857929
Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe. 2009;5:487–97.
pubmed: 19454352 pmcid: 2824856 doi: 10.1016/j.chom.2009.05.002
Gao Y, Yu S, Chen M, Wang X, Pan L, Wei B, et al. cFLIP(S) regulates alternative NLRP3 inflammasome activation in human monocytes. Cell Mol Immunol. 2023;20:1203–15.
pubmed: 37591930 doi: 10.1038/s41423-023-01077-y
Huai W, Zhao R, Song H, Zhao J, Zhang L, Zhang L, et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun. 2014;5:4738.
pubmed: 25141024 doi: 10.1038/ncomms5738
Barry R, John SW, Liccardi G, Tenev T, Jaco I, Chen CH, et al. SUMO-mediated regulation of NLRP3 modulates inflammasome activity. Nat Commun. 2018;9:3001.
pubmed: 30069026 pmcid: 6070540 doi: 10.1038/s41467-018-05321-2
He M, Chiang HH, Luo H, Zheng Z, Qiao Q, Wang L, et al. An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance. Cell Metab. 2020;31:580–91.e5.
pubmed: 32032542 pmcid: 7104778 doi: 10.1016/j.cmet.2020.01.009
Chen MY, Ye XJ, He XH, Ouyang DY. The signaling pathways regulating NLRP3 inflammasome activation. Inflammation. 2021;44:1229–45.
pubmed: 34009550 doi: 10.1007/s10753-021-01439-6
Li J, Zhang Y, Zhang Y, Lu S, Miao Y, Yang J, et al. GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation. Redox Biol. 2018;17:386–99.
pubmed: 29860106 pmcid: 6007174 doi: 10.1016/j.redox.2018.04.021
Hale KK, Trollinger D, Rihanek M, Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol. 1999;162:4246–52.
pubmed: 10201954 doi: 10.4049/jimmunol.162.7.4246
Luo Q, Schnoder L, Hao W, Litzenburger K, Decker Y, Tomic I, et al. p38alpha-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer’s disease mice. Aging Cell. 2022;21:e13679.
pubmed: 35909315 pmcid: 9381888 doi: 10.1111/acel.13679
Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb Perspect Biol. 2016;8:a006072.
pubmed: 27698029 pmcid: 5046695 doi: 10.1101/cshperspect.a006072
Zhang X, Du H, Shi QH, Gong BA. Loss of GSNOR increases abiotic stress sensitivity via regulating MAPK-ethylene cascade signaling in Solanum lycopersicum L. Environ Exp Bot. 2022;199.
He Y, Franchi L, Nunez G. TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol. 2013;190:334–9.
pubmed: 23225887 doi: 10.4049/jimmunol.1202737
Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell. 2004;116:617–28.
pubmed: 14980227 doi: 10.1016/S0092-8674(04)00131-X
Rizza S, Cardaci S, Montagna C, Di Giacomo G, De Zio D, Bordi M, et al. S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc Natl Acad Sci USA. 2018;115:E3388–e97.
pubmed: 29581312 pmcid: 5899480 doi: 10.1073/pnas.1722452115
He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9:2550.
pubmed: 29959312 pmcid: 6026158 doi: 10.1038/s41467-018-04947-6
Huang B, Qian Y, Xie S, Ye X, Chen H, Chen Z, et al. Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y(12) signaling pathway. Cell Mol Immunol. 2021;18:1278–89.
pubmed: 32523112 doi: 10.1038/s41423-020-0444-5
Liu Q, Su LY, Sun C, Jiao L, Miao Y, Xu M, et al. Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation. Redox Biol. 2020;34:101560.
pubmed: 32413745 pmcid: 7225735 doi: 10.1016/j.redox.2020.101560
Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49:842–56.e7.
pubmed: 30366764 doi: 10.1016/j.immuni.2018.08.021
Yi W, Zhang Y, Liu B, Zhou Y, Liao D, Qiao X, et al. Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration. Cell Rep. 2021;34:108922.
pubmed: 33789111 pmcid: 9204508 doi: 10.1016/j.celrep.2021.108922
Yu D, Long Y, Xu L, Han JB, Xi J, Xu J, et al. Infectivity of SARS-CoV-2 and protection against reinfection in rats. Zool Res. 2022;43:945–48.
pubmed: 36208120 pmcid: 9700504 doi: 10.24272/j.issn.2095-8137.2022.339
Wang X, Cai J, Lin B, Ma M, Tao Y, Zhou Y, et al. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair. Immunity. 2021;54:1123–36.e8.
pubmed: 34107271 doi: 10.1016/j.immuni.2021.05.007
Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 2012;36:742–54.
pubmed: 22503542 pmcid: 3658309 doi: 10.1016/j.immuni.2012.03.012
Luo R, Fan Y, Yang J, Ye M, Zhang DF, Guo K, et al. A novel missense variant in ACAA1 contributes to early-onset Alzheimer’s disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. Signal Transduct Target Ther. 2021;6:325.
pubmed: 34465723 pmcid: 8408221 doi: 10.1038/s41392-021-00748-4
Ye MS, Zhang JY, Yu DD, Xu M, Xu L, Lv LB, et al. Comprehensive annotation of the Chinese tree shrew genome by large-scale RNA sequencing and long-read isoform sequencing. Zool Res. 2021;42:692–709.
pubmed: 34581030 pmcid: 8645884 doi: 10.24272/j.issn.2095-8137.2021.272
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.
pubmed: 24695404 pmcid: 4103590 doi: 10.1093/bioinformatics/btu170
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.
pubmed: 34557778
Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847–9.
pubmed: 27207943 doi: 10.1093/bioinformatics/btw313

Auteurs

Qianjin Liu (Q)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China. liuqianjin@mail.kiz.ac.cn.

Lijin Jiao (L)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.

Mao-Sen Ye (MS)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.

Zhiyu Ma (Z)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.
Kunming College of Life Science, University of Chinese Academy of Sciences, 650204, Kunming, Yunnan, China.

Jinsong Yu (J)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.

Ling-Yan Su (LY)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.

Wei-Yin Zou (WY)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.
Kunming College of Life Science, University of Chinese Academy of Sciences, 650204, Kunming, Yunnan, China.

Lu-Xiu Yang (LX)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China.

Chang Chen (C)

Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101, Beijing, China.

Yong-Gang Yao (YG)

Key Laboratory of Genetic Evolution & Animal Models, and Key Laboratory of Animal Models & Human Disease Mechanisms of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China. yaoyg@mail.kiz.ac.cn.
Kunming College of Life Science, University of Chinese Academy of Sciences, 650204, Kunming, Yunnan, China. yaoyg@mail.kiz.ac.cn.
KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, Yunnan, China. yaoyg@mail.kiz.ac.cn.
National Research Facility for Phenotypic & Genetic Analysis of Model Animals (Primate Facility), National Resource Center for Non-Human Primates, Kunming Institute of Zoology, Chinese Academy of Sciences, 650201, Kunming, China. yaoyg@mail.kiz.ac.cn.

Classifications MeSH